表紙
市場調査レポート

Med Discovery SA - 製品パイプライン分析

Med Discovery SA - Product Pipeline Review - 2014

発行 Global Markets Direct 商品コード 199734
出版日 ページ情報 英文 23 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
Med Discovery SA - 製品パイプライン分析 Med Discovery SA - Product Pipeline Review - 2014
出版日: 2014年08月14日 ページ情報: 英文 23 Pages
概要

Med Discovery SA は、前立腺、膀胱、卵巣の各癌治療用タンパク質の開発に取り組むバイオ製薬企業です。

当レポートでは、Med Discovery SAにおける治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Med Discovery SAの基本情報

Med Discovery SAの概要

  • 主要情報
  • 企業情報

Med Discovery SA:R&Dの概要

  • 主な治療範囲

Med Discovery SA:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • パートナー製品
    • パートナー製品/併用療法モダリティ

Med Discovery SA:パイプライン製品の概況

  • 治験段階にあるパイプライン製品
    • 第I相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ

Med Discovery SA:薬剤プロファイル

  • MDPK-67b
  • MDP-01
  • MDRG-01

Med Discovery SA:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Med Discovery SA:休止中のプロジェクト

Med Discovery SA:本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC06152CDB

Summary

Global Markets Direct's, 'Med Discovery SA - Product Pipeline Review - 2014', provides an overview of the Med Discovery SA's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Med Discovery SA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Med Discovery SA including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Med Discovery SA's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Med Discovery SA's pipeline products

Reasons to buy

  • Evaluate Med Discovery SA's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Med Discovery SA in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Med Discovery SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Med Discovery SA and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Med Discovery SA
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Med Discovery SA and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Med Discovery SA Snapshot
    • Med Discovery SA Overview
    • Key Information
    • Key Facts
  • Med Discovery SA - Research and Development Overview
    • Key Therapeutic Areas
  • Med Discovery SA - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Med Discovery SA - Pipeline Products Glance
    • Med Discovery SA - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Med Discovery SA - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Med Discovery SA - Drug Profiles
    • MDPK-67b
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MDP-01
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MDRG-01
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Med Discovery SA - Pipeline Analysis
    • Med Discovery SA - Pipeline Products by Target
    • Med Discovery SA - Pipeline Products by Route of Administration
    • Med Discovery SA - Pipeline Products by Molecule Type
    • Med Discovery SA - Pipeline Products by Mechanism of Action
  • Med Discovery SA - Dormant Projects
  • Med Discovery SA - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Med Discovery SA, Key Information
  • Med Discovery SA, Key Facts
  • Med Discovery SA - Pipeline by Indication, 2014
  • Med Discovery SA - Pipeline by Stage of Development, 2014
  • Med Discovery SA - Monotherapy Products in Pipeline, 2014
  • Med Discovery SA - Partnered Products in Pipeline, 2014
  • Med Discovery SA - Partnered Products/ Combination Treatment Modalities, 2014
  • Med Discovery SA - Phase I, 2014
  • Med Discovery SA - Preclinical, 2014
  • Med Discovery SA - Pipeline by Target, 2014
  • Med Discovery SA - Pipeline by Route of Administration, 2014
  • Med Discovery SA - Pipeline by Molecule Type, 2014
  • Med Discovery SA - Pipeline Products by Mechanism of Action, 2014
  • Med Discovery SA - Dormant Developmental Projects,2014
  • Med Discovery SA, Other Locations

List of Figures

  • Med Discovery SA - Pipeline by Top 10 Indication, 2014
  • Med Discovery SA - Pipeline by Stage of Development, 2014
  • Med Discovery SA - Monotherapy Products in Pipeline, 2014
  • Med Discovery SA - Pipeline by Top 10 Target, 2014
  • Med Discovery SA - Pipeline by Top 10 Route of Administration, 2014
  • Med Discovery SA - Pipeline by Top 10 Molecule Type, 2014
  • Med Discovery SA - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top